- Visibility 100 Views
- Downloads 124 Downloads
- Permissions
- DOI 10.18231/j.ijced.10908.1646526679
-
CrossMark
Atypical presentation of bowens disease
- Author Details:
-
Nikita Narayanan
-
Vaishnavi Sabapathi *
-
Gopalakrishnan Kunjaram
-
Kavya Gowda
-
Jayakar Thomas
Nikita Narayanan
Vaishnavi Sabapathi *
Gopalakrishnan Kunjaram
Kavya Gowda
Jayakar Thomas
In-situ squamous cell carcinoma of the epidermis is known as Bowen's disease (BD). BD has a complex aetiology and a significant prevalence in the Caucasian population. Although it can affect other regions of the skin, BD is most common in photo exposed areas. Typically, lesions are isolated. The lesion's age, origin, and level of keratinisation all affect the appearance of BD. Before an overt squamous cell carcinoma, BD is referred to as the "lull before the storm." The most reliable diagnostic technique for confirming the diagnosis is histopathology. Adjuvant techniques for diagnosing BD include immunohistochemistry, dermoscopy, and reflectance confocal microscopy. In this unusual instance of Bowen's disease, we show a single plaque on the thigh, which is not normally exposed to sunlight.
References
- Cox NH, Eedy DJ, Morton CA. Guidelines for management of Bowen's disease: 2006 update. Br J Dermatol. 2007;156(1):11–21.
- Ragi G, Turner MS, Klein LE, Stoll Jr HL. Pigmented Bowen's disease and review of 420 Bowen's disease lesions. Dermatol Surg. 1988;14(7):765–9.
- Pravin A, Kulkarni OD, Thomas J. Bowen’s disease arising over a scar of BCG vaccination: a rare case report. Int J Sci Res. 2019;8(9):55–6.
- Maria Wozniak-Rito A, Rudnicka L. Bowen’s disease in dermoscopy. Acta Dermatovenerologica Croatica. 2018;26(2):157–
- Palaniappan V, Karthikeyan K. Bowen's disease. Indian Dermatol Online J. 2022;13(2):177–9.
- Neubert T, Lehmann P. Bowen’s disease–a review of newer treatment options. Ther Clin Risk Manag. 2008;4(5):1085–95.
- Gately S. The contributions of cyclooxygenase-2 to tumor angiogenesis. Cancer Metastasis Rev. 2000;19(1-2):19–27.
- Hengge UR, Benninghoff B, Ruzicka T, Goos M. Topical immunomodulators—progress towards treating inflammation, infection, and cancer. Lancet Infect Dis. 2001;1(3):189–98.
- Braathen LR, Szeimies RM, Basset-Seguin N, Bissonnette R, Foley P, Pariser D, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. J Am Acad Dermatol. 2007;56(1):125–43.